Health

The recent actions taken by the Trump administration have raised alarm over the viability of public health communication in the United States. Instructions to pause external communications from vital health agencies, including the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes
0 Comments
The administration of President Donald Trump marked a significant departure from previous U.S. foreign and health policies, particularly regarding the World Health Organization (WHO). In a high-profile executive order on his first day back in office, Trump announced his intentions to withdraw the United States from the WHO, a move that sparked controversy and debate
0 Comments
The use of GLP-1 receptor agonists in the management of type 2 diabetes has garnered considerable attention in recent years, particularly with the mounting evidence of their broader health impacts beyond glycemic control. A comprehensive analysis of Veterans Affairs (VA) data involving nearly two million individuals has shed light on the dual nature of these
0 Comments
In the current landscape of healthcare, practices are facing unprecedented challenges. Economic pressures and a significant departure of personnel have led to a phenomenon known as “skimpflation.” This term encapsulates a gradual but alarming decline in the quality of healthcare services due to cost-cutting measures and workforce shortages. Unlike “shrinkflation,” which pertains to the reduction
0 Comments
The healthcare landscape in the United States is undergoing significant changes, particularly in how international medical graduates (IMGs) can attain licensure. Massachusetts recently took a notable step in this area by enacting the Physician Pathway Act. This legislation marks a critical development for IMGs, providing them with alternative pathways to permanent licensure while also addressing
0 Comments
In the wake of recent controversies surrounding the U.S. Food and Drug Administration (FDA) and its accelerated approval pathway, the Health and Human Services (HHS) Office of Inspector General (OIG) has issued a clarion call for reform. This pathway allows for expedited drug approval under certain conditions, primarily focused on treating severe and life-threatening conditions.
0 Comments
The U.S. Food and Drug Administration (FDA) has taken a significant step towards transforming public health by unveiling a proposed regulation aimed at minimizing the nicotine content in combustible tobacco products. Announced on Wednesday, this proposal focuses primarily on cigarettes, roll-your-own tobacco, certain types of cigars, and pipe tobacco. With an ambition to curb addiction,
0 Comments